SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-268012
Filing Date
2011-10-11
Accepted
2011-10-11 12:06:43
Documents
3
Period of Report
2011-10-05
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d242310d8k.htm 8-K 17221
2 PRESS RELEASE d242310dex991.htm EX-99.1 6984
3 GRAPHIC g242310ex99_1logo.jpg GRAPHIC 7779
  Complete submission text file 0001193125-11-268012.txt   36339
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-23186 | Film No.: 111134602
SIC: 2836 Biological Products, (No Diagnostic Substances)